Elanco Animal Health Total Assets
Elanco Animal Health total assets. Based on the latest financial reports, Elanco Animal Health (ELAN) holds total assets worth $13.56 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Elanco Animal Health cash conversion from operations for how efficiently the company converts equity into cash flow.
Total Assets of Elanco Animal Health (2016–2025)
Total assets of Elanco Animal Health from 2016 to 2025. This chart illustrates how Elanco Animal Health's total assets have evolved over time, based on quarterly financial data. See ELAN stock price for real-time trading data and today's change.
Elanco Animal Health - Asset Composition Analysis
Elanco Animal Health Total Assets Breakdown (December 2025)
Elanco Animal Health total assets breakdown as of December 2025. Elanco Animal Health's total assets of $13.56 Billion consist of 25.9% current assets and 74.1% non-current assets. Explore Elanco Animal Health current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.1% |
| Accounts Receivable | $940.00 Million | 7.0% |
| Inventory | $1.74 Billion | 13.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.41 Billion | 25.5% |
| Goodwill | $4.78 Billion | 35.8% |
Asset Composition Trend (2016–2025)
This chart illustrates how Elanco Animal Health's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elanco Animal Health's current assets represent 25.9% of total assets in 2025, an increase from 24.0% in 2016.
- Cash Position: Cash and equivalents constituted 4.1% of total assets in 2025, up from 3.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, a decrease from 63.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 35.8% of total assets.
Elanco Animal Health Competitors by Total Assets
Key competitors of Elanco Animal Health based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
USA | $199.45 Million |
|
Zhejiang Medicine Co Ltd
SHG:600216
|
China | CN¥14.18 Billion |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
China | CN¥2.53 Billion |
|
Dezhan HealthCare Co Ltd
SHE:000813
|
China | CN¥4.77 Billion |
|
Chongqing Pharscin Pharmaceutical Co Ltd
SHE:002907
|
China | CN¥2.00 Billion |
Elanco Animal Health - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.05 | 2.60 | 2.32 |
| Quick Ratio | 1.10 | 1.40 | 1.30 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.95 Billion | $2.22 Billion | $1.80 Billion |
Elanco Animal Health - Advanced Valuation Insights
This section examines the relationship between Elanco Animal Health's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.68 |
| Latest Market Cap to Assets Ratio | 0.83 |
| Asset Growth Rate (YoY) | 5.9% |
| Total Assets | $13.36 Billion |
| Market Capitalization | $11.05 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Elanco Animal Health's assets close to their book value (0.83x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: Elanco Animal Health's assets grew by 5.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Elanco Animal Health (2016–2025)
The table below shows the annual total assets of Elanco Animal Health from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $13.36 Billion | +5.90% |
| 2024-12-31 | $12.61 Billion | -12.17% |
| 2023-12-31 | $14.36 Billion | -7.29% |
| 2022-12-31 | $15.49 Billion | -5.99% |
| 2021-12-31 | $16.48 Billion | -6.87% |
| 2020-12-31 | $17.69 Billion | +96.90% |
| 2019-12-31 | $8.99 Billion | +0.32% |
| 2018-12-31 | $8.96 Billion | +0.18% |
| 2017-12-31 | $8.94 Billion | +10.38% |
| 2016-12-31 | $8.10 Billion | -- |
About Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide … Read more